The Greek Union of Judges and Prosecutors called for “calmness and sobriety” on Friday (16 February), following a lawsuit by former Prime Minister Antonis Samaras against Premier Alexis Tsipras and Prosecutor of Corruption Eleni Touloupaki over the Novartis scandal.
The most popularly supported public service in the UK, the national health service (NHS) is also the country's largest single employer. Throughout its nearly 70 year history, it has been reliant on migrant workers and may face a serious shortage of staff because of Brexit.
A merger between Dow Chemical and DuPont (DowDuPont) aims to accelerate innovation in agriculture to help all farm sizes, as well as rapidly facing up to future challenges, DowDuPont’s Pierre Flye Sainte Marie told EURACTIV.com in an interview.
The European Commission will decide next month whether to launch legal cases against nine member states that are accused of breaking air pollution action, after additional information was submitted at the eleventh hour.
Since 1990, the production of "green" electricity in Germany has increased by 1,000% and export rates, according to preliminary data for 2017, just smashed another record. EURACTIV Poland’s partner WysokieNapiecie.pl reports.
The smooth transition of the EU drug agency from London to Amsterdam is threatened by delays in the Netherlands, whose bid to win the agency may have been misleading, a top representative of Italian pharmaceuticals told EURACTIV.com.
A probe into illegal practices of Swiss drugmaker Novartis in Greece, involving thousands of state officials and doctors, has opened the Pandora’s Box in Greek politics as local media have named ten former bigwigs from opposition parties as being targeted by the investigation.
The Dutch Safety Board has concluded that cross-border cooperation on nuclear safety between the Netherlands, Belgium and Germany leaves a lot to be desired. A new report warns that the current state-of-play could lead to “confusion and unrest” among the population in the event of an incident.
Slovenia joined the “Valletta Declaration”, an alliance of southern EU member states, which aims to explore strategies to jointly negotiate prices with the pharma industry, as well as Croatia with an observer status.
The European Commission unveiled plans for a pan-EU Health Technology Assessment (HTA) law on Wednesday (31 January), with EU health chief Vytenis Andriukaitis promising that they would help patients take advantage of “an exciting era for innovation in health".